Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-22
1990-02-06
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514256, 514326, 514341, 514397, 514404, 544333, 544371, 544405, 546211, 546279, 548336, 548364, 548374, A61K 31415, C07D40312
Patent
active
048988804
ABSTRACT:
N-[(heterocycle)alkyl]-3,4 (or 4,5)-diaryl-1H-pyrazole-1-acetamides and pyrazole-1-propanamides, useful for treating cardiac arrhythmias in mammals, are prepared by reacting a lower-alkyl ester of pyrazole-1-acetic or propanoic acid with an appropriate (heterocycle-alkyl) amine or by reacting a pyrazole-1-acetic or propanoic acid with an appropriate (heterocycle-alkyl)amine.
REFERENCES:
patent: 4182895 (1980-01-01), Bailey
Ezrin et al. FASEB Journal 2,A1557 (1988).
Bailey Denis M.
D'Ambra Thomas E.
Lesher George Y.
DuPont Paul E.
Hansen Philip E.
Ramsuer Robert W.
Sterling Drug Inc.
LandOfFree
N-(heterocycle)alkyl)-1H-pyrazole-1-alkanamides as antiarrhythmi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(heterocycle)alkyl)-1H-pyrazole-1-alkanamides as antiarrhythmi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(heterocycle)alkyl)-1H-pyrazole-1-alkanamides as antiarrhythmi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442068